C07K 1 - General processes for the preparation of peptides

Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/2002
11/27/2002	CN1382154A Basic monocyclic compounds having NK2 antagonist action processes for their preparation and formulations containing them
11/26/2002	US6486354 Solid phase supports
11/26/2002	US6486306 Filtration
11/26/2002	US6486125 Synthesis of soluble β-sheet forming peptides
11/26/2002	US6485718 Converting a polypeptide containing a serine as its n-terminal amino acid to an aldehyde; converting the amine of a synthetic particle to a oxiamine; and combining aldehyde polypeptide to oxiamine
11/26/2002	CA2087164C Target specific antibody-superantigen conjugates and their preparation
11/26/2002	CA1341401C Immunosuppressant factor derived from human glioblastoma cells
11/21/2002	WO2003099841A2 Peptides and the use thereof in darkening the skin
11/21/2002	WO2002092833A2 Arrays of biological membranes and methods and use thereof
11/21/2002	WO2002092829A1 Process for producing peptide
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002092615A2 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
11/21/2002	WO2002092200A1 Methods and apparatus for electrophoresis of prior-cast, hydratable separation media
11/21/2002	WO2002092118A1 Global analysis of protein activities using proteome chips
11/21/2002	WO2002074784A3 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain
11/21/2002	WO2002068933A3 Small molecule design against drug resistant mutants using directed evolution
11/21/2002	WO2001028511A9 Selective removal of contaminants from a surface using magnets
11/21/2002	US20020173621 Generation of preferential fusion protein; obtain cell, transform with expression vector coding fusion polypeptide, propagate, express vector, recover fusion protein
11/21/2002	US20020173468 Modified cytostatic agents
11/21/2002	US20020173052 Method for performing submicroliter crystallization experiments with high experiment to experiment precision
11/21/2002	US20020173051 Solid phase synthesis supports and methods
11/21/2002	US20020172718 Fibrinogen and fibronectin-containing solution is treated with a precipitating formulation which comprises components that modify solubility of fibrinogen and/or fibronectin, so that in a single-step precipitation, precipitate is formed
11/21/2002	US20020170859 Purification of biological substances
11/21/2002	US20020170831 Apparatus and method for separation of molecules and movement of fluids
11/21/2002	DE10124058A1 Use of green fluorescent family proteins as affinity chromatography tags, useful for isolation of recombinant proteins, especially proteins from Anemonia sulcata
11/21/2002	CA2447251A1 Arrays of biological membranes and methods and use thereof
11/21/2002	CA2446867A1 Global analysis of protein activities using proteome chips
11/21/2002	CA2446050A1 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
11/21/2002	CA2445539A1 Methods and apparatus for electrophoresis of prior-cast, hydratable separation media
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/20/2002	EP1258497A2 Conjugates of factor VIII and a biocompatible polymer
11/20/2002	EP1258492A1 N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases
11/20/2002	EP1258288A2 Method and apparatus for chemical and biochemical reactions using photo-generated reagents
11/20/2002	EP1257829A2 Complementation assay assessing protein solubility and folding
11/20/2002	EP1257586A2 Use of an anion exchange resin (epm-7) as solid support for peptide synthesis and affinity chromatography
11/20/2002	EP1257577A2 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds
11/20/2002	EP1257571A1 Method of purifying a hydrophobin present in a hydrophobin-containing solution
11/20/2002	EP1257564A1 Process of purification of hcg and recombinant hcg purified by that method
11/20/2002	EP1257562A2 Novel resin materials and their use for recovering proteins or peptides
11/20/2002	EP1064312B1 Quaternary ammonium polymer, its preparation, its use for separating biomolecules
11/20/2002	EP0954326A4 A process for viral inactivation of lyophilized blood proteins
11/20/2002	EP0832268B1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors
11/19/2002	CA2312667C Novel cytokine
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2087325C Method of purifying .alpha.-l-aspartyl-l-phenylalanine methyl ester
11/19/2002	CA2063580C Receptor assay for fk-506
11/19/2002	CA1341399C Intercellular adhesion molecules and their binding ligands
11/14/2002	WO2002090985A1 Peptide-immobilized baseboard and method of assaying target protein using the same
11/14/2002	WO2002090923A2 Methods for assembling protein microarrays
11/14/2002	WO2002090542A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
11/14/2002	WO2002090388A1 Derivatives of exendin
11/14/2002	WO2002090379A1 Process for inactivating prions in lipoproteins
11/14/2002	WO2002089971A2 Hybrid method for the production of carriers for analyte determination
11/14/2002	WO2002062370A3 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
11/14/2002	US20020169282 Generating peptide joined to solid support; generate solid support, incubate with peptide, join peptide to support, incubate with additional peptides, join to support, recover support
11/14/2002	US20020169281 Peptoids incorporating chemoselective functionalities
11/14/2002	US20020169133 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
11/14/2002	US20020168756 selective transport from an aqueous phase to an oil phase; particle size reversibly increased and decreased by irradiation; filter membrane; biodegradable; azo and an azoxy cis-trans isomers reversibly transformed by UV and light
11/14/2002	US20020168753 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
11/14/2002	US20020168705 Generate protein for X-ray crystallographic analysis; obtain cell extract, incubate with protein synthesis mixture and label, detect signal from preferential protein
11/14/2002	US20020168704 Method for producing a protein hydrolysate with low bitterness
11/14/2002	US20020168686 Evaluating activity of proteins; obtain protein, incubate with modulators, generate activity spectrum, classify protein
11/14/2002	US20020168634 Detecting genes associated with cell propagation; generate library of preferential cell, incubate with grid, mutagenize, propagate, harvest, extract and isolate nucleotide sequences, incubate with probes, detect pattern, compare to control
11/14/2002	US20020168414 Rapid dehydration of proteins
11/14/2002	US20020168383 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
11/14/2002	DE10122357A1 Hybridverfahren zur Herstellung von Trägern für die Analytbestimmung Hybrid Process for the preparation of supports for the analyte
11/14/2002	DE10111853A1 Verfahren und Vorrichtung zur Aufarbeitung von Proteinen in Gelen Method and apparatus for processing of proteins in gels
11/14/2002	CA2446417A1 Methods for assembling protein microarrays
11/14/2002	CA2446394A1 Insulinotropic peptide derivatives
11/13/2002	EP1256001A2 Mapping of differential display of proteins
11/13/2002	EP1255984A2 Microfluid device with sample injector and method of use
11/13/2002	EP1255869A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255826A2 Protein design automation for protein libraries
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255769A2 Universal procedure for refolding recombinant proteins
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255716A1 Segment synthesis
11/13/2002	EP0983232B1 Guanidinylation reagents
11/13/2002	CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
11/13/2002	CN1379090A Process for preparing calf rennase
11/12/2002	US6479644 Method for purifying and enriching molecules
11/12/2002	US6479300 Metal loaded ligand bound membranes for metal ion affinity chromatography
11/12/2002	US6479296 Solid phase precipitation and extraction
11/12/2002	US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/12/2002	US6479258 Non-stochastic generation of genetic vaccines
11/12/2002	US6479257 Method of activating protein and an apparatus therefor
11/12/2002	US6479049 Methods and compositions for the dry powder formulation of interferons
11/12/2002	US6478969 Shear separation method and system
11/12/2002	CA2204535C Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/12/2002	CA2138647C Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/12/2002	CA2055963C Chimeric fibroblast growth factor
11/07/2002	WO2002088367A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus

1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 518